| Name | phosphoglycerate dehydrogenase |
| Description | This gene encodes the enzyme which is involved in the early steps of L-serine synthesis in animal cells. L-serine is required for D-serine and other amino acid synthesis. The enzyme requires NAD/NADH as a cofactor and forms homotetramers for activity. Mutations in this gene have been found in a family with congenital microcephaly, psychomotor retardation and other symptoms. Multiple alternatively spliced transcript variants have been found, however the full-length nature of most are not known. [provided by RefSeq, Aug 2011] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nPHGDH is the rate‐limiting enzyme that diverts the glycolytic intermediate 3‐phosphoglycerate into the serine biosynthesis pathway, a process critical for generating serine, glycine, nucleotides, and key tricarboxylic acid cycle intermediates. In several human cancers—including breast, melanoma, pancreatic, lung, and renal carcinomas—elevated PHGDH expression and gene amplification have been shown to drive increased metabolic flux toward serine production, thereby supporting rapid cell proliferation, survival under low‐serine conditions, and metabolic reprogramming (for example, by fueling redox balance and anaplerosis). These studies also reveal that enhanced PHGDH activity underpins aggressive tumor phenotypes, cancer stem‐like properties, and even drug resistance, as demonstrated by its involvement in Sorafenib resistance in hepatocellular carcinoma and its requirement for mTORC1‐mediated growth signaling in metastatic lesions."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "11"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its metabolic function, PHGDH is subject to multiple layers of regulation that modulate its enzymatic activity and, consequently, tumor behavior. Post‐translational modifications such as ubiquitination and monoubiquitination—as mediated by factors like Parkin and specific E3 ligase complexes—can either target PHGDH for proteasomal degradation or enhance its activity to promote metastatic progression. Other regulatory mechanisms include control by noncoding RNAs and histone modifiers (for instance, through modulation by KDM4B), as well as inhibitory strategies using small molecules like oridonin that bind novel allosteric sites. Together, these modifications affect not only serine and nucleotide metabolism but also redox homeostasis and pro‐survival signaling pathways, suggesting that PHGDH is an attractive target for combination therapies in cancer."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "12", "end_ref": "22"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its roles in oncogenesis, altered PHGDH function is implicated in diverse developmental and non‐malignant conditions. Inherited loss‐of‐function mutations in PHGDH cause severe serine‐deficiency disorders such as Neu–Laxova syndrome, characterized by multiple congenital anomalies and perinatal lethality, while defects in serine metabolism have also been associated with neurologic and retinal degenerative conditions. Furthermore, PHGDH regulation is important in normal physiology—for example, in endometrial differentiation and in skeletal muscle where PHGDH activity supports protein synthesis and mTORC1 signaling. Alterations in local tissue metabolism, as observed in fibrotic diseases and even in varicocele‐associated infertility, further underscore the broad functional impact of PHGDH in maintaining cellular and tissue homeostasis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "23", "end_ref": "32"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Richard Possemato, Kevin M Marks, Yoav D Shaul, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Functional genomics reveal that the serine synthesis pathway is essential in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature10350"}], "href": "https://doi.org/10.1038/nature10350"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21760589"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21760589"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Jason W Locasale, Alexandra R Grassian, Tamar Melman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.890"}], "href": "https://doi.org/10.1038/ng.890"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21804546"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21804546"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Zhang Jing, Wei Heng, Ding Aiping, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression and clinical significance of phosphoglycerate dehydrogenase and squamous cell carcinoma antigen in cervical cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Gynecol Cancer (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/IGC.0b013e3182a0c068"}], "href": "https://doi.org/10.1097/IGC.0b013e3182a0c068"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24247658"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24247658"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Irina Gromova, Pavel Gromov, Naoko Honma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High level PHGDH expression in breast is predominantly associated with keratin 5-positive cell lineage independently of malignancy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Oncol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molonc.2015.05.003"}], "href": "https://doi.org/10.1016/j.molonc.2015.05.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26026368"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26026368"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Shinkyo Yoon, Jong Gwang Kim, An Na Seo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Clinical Implication of Serine Metabolism-Associated Enzymes in Colon Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncology (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000439571"}], "href": "https://doi.org/10.1159/000439571"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26439504"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26439504"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Boxi Zhang, Adi Zheng, Per Hydbring, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PHGDH Defines a Metabolic Subtype in Lung Adenocarcinomas with Poor Prognosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.celrep.2017.05.067"}], "href": "https://doi.org/10.1016/j.celrep.2017.05.067"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28614715"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28614715"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Hirofumi Yoshino, Nijiro Nohata, Kazutaka Miyamoto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PHGDH as a Key Enzyme for Serine Biosynthesis in HIF2α-Targeting Therapy for Renal Cell Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-17-1589"}], "href": "https://doi.org/10.1158/0008-5472.CAN-17-1589"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28951458"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28951458"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Zhiwang Song, Chan Feng, Yonglin Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PHGDH is an independent prognosis marker and contributes cell proliferation, migration and invasion in human pancreatic cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2017.11.014"}], "href": "https://doi.org/10.1016/j.gene.2017.11.014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29128633"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29128633"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Tanveer Sharif, Emma Martell, Cathleen Dai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Phosphoglycerate dehydrogenase inhibition induces p-mTOR-independent autophagy and promotes multilineage differentiation in embryonal carcinoma stem-like cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-018-0997-8"}], "href": "https://doi.org/10.1038/s41419-018-0997-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30250195"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30250195"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Mark R Sullivan, Katherine R Mattaini, Emily A Dennstedt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased Serine Synthesis Provides an Advantage for Tumors Arising in Tissues Where Serine Levels Are Limiting."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Metab (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cmet.2019.02.015"}], "href": "https://doi.org/10.1016/j.cmet.2019.02.015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30905671"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30905671"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Lai Wei, Derek Lee, Cheuk-Ting Law, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-019-12606-7"}], "href": "https://doi.org/10.1038/s41467-019-12606-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31615983"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31615983"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Qing Li, Haifeng Gao, Shuyan Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA PlncRNA-1 overexpression inhibits the growth of breast cancer by upregulating TGF-β1 and downregulating PHGDH."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Breast Cancer (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12282-018-0858-4"}], "href": "https://doi.org/10.1007/s12282-018-0858-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29626321"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29626321"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Michael A Reid, Annamarie E Allen, Shiyu Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Serine synthesis through PHGDH coordinates nucleotide levels by maintaining central carbon metabolism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-018-07868-6"}], "href": "https://doi.org/10.1038/s41467-018-07868-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30575741"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30575741"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Hirofumi Yoshino, Hideki Enokida, Yoichi Osako, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization of PHGDH expression in bladder cancer: potential targeting therapy with gemcitabine/cisplatin and the contribution of promoter DNA hypomethylation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Oncol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/1878-0261.12697"}], "href": "https://doi.org/10.1002/1878-0261.12697"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32386122"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32386122"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Min Ji Jeon, Mi-Hyeon You, Ji Min Han, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High Phosphoglycerate Dehydrogenase Expression Induces Stemness and Aggressiveness in Thyroid Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Thyroid (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/thy.2020.0105"}], "href": "https://doi.org/10.1089/thy.2020.0105"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32438862"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32438862"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Gianmarco Rinaldi, Erica Pranzini, Joke Van Elsen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "In Vivo Evidence for Serine Biosynthesis-Defined Sensitivity of Lung Metastasis, but Not of Primary Breast Tumors, to mTORC1 Inhibition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2020.11.027"}], "href": "https://doi.org/10.1016/j.molcel.2020.11.027"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33340488"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33340488"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Hanyu Xu, Xiaoyu Qing, Qian Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dimerization of PHGDH via the catalytic unit is essential for its enzymatic function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jbc.2021.100572"}], "href": "https://doi.org/10.1016/j.jbc.2021.100572"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33753166"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33753166"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Kevin Eade, Marin L Gantner, Joseph A Hostyk, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Serine biosynthesis defect due to haploinsufficiency of PHGDH causes retinal disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Metab (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s42255-021-00361-3"}], "href": "https://doi.org/10.1038/s42255-021-00361-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33758422"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33758422"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Yuping Tan, Xia Zhou, Yanqiu Gong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Biophysical and biochemical properties of PHGDH revealed by studies on PHGDH inhibitors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Mol Life Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00018-021-04022-2"}], "href": "https://doi.org/10.1007/s00018-021-04022-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34971423"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34971423"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Kui Wang, Li Luo, Shuyue Fu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-023-36708-5"}], "href": "https://doi.org/10.1038/s41467-023-36708-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36823188"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36823188"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Xin-Yu Wang, Hong-Ming Li, Ran Xia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "KDM4B down-regulation facilitated breast cancer cell stemness via PHGDH upregulation in H3K36me3-dependent manner."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biochem (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11010-023-04777-1"}], "href": "https://doi.org/10.1007/s11010-023-04777-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37249813"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37249813"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Liliang Shen, Junfeng Zhang, Zongtai Zheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PHGDH Inhibits Ferroptosis and Promotes Malignant Progression by Upregulating SLC7A11 in Bladder Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Biol Sci (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/ijbs.74546"}], "href": "https://doi.org/10.7150/ijbs.74546"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36147463"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36147463"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Sanghamitra Dey, Rodney L Burton, Gregory A Grant, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structural analysis of substrate and effector binding in Mycobacterium tuberculosis D-3-phosphoglycerate dehydrogenase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochemistry (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/bi800212b"}], "href": "https://doi.org/10.1021/bi800212b"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18627175"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18627175"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Tohru Ohnuma, Nobuto Shibata, Hitoshi Maeshima, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association analysis of glycine- and serine-related genes in a Japanese population of patients with schizophrenia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Prog Neuropsychopharmacol Biol Psychiatry (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.pnpbp.2009.02.004"}], "href": "https://doi.org/10.1016/j.pnpbp.2009.02.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19223009"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19223009"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Hongling Du, Danielle Vitiello, Jennifer L Sarno, et al. "}, {"type": "b", "children": [{"type": "t", "text": "3-Phosphoglycerate dehydrogenase expression is regulated by HOXA10 in murine endometrium and human endometrial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Reproduction (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1530/REP-08-0376"}], "href": "https://doi.org/10.1530/REP-08-0376"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19778996"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19778996"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Ranad Shaheen, Zuhair Rahbeeni, Amal Alhashem, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neu-Laxova syndrome, an inborn error of serine metabolism, is caused by mutations in PHGDH."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ajhg.2014.04.015"}], "href": "https://doi.org/10.1016/j.ajhg.2014.04.015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24836451"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24836451"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Rocio Acuna-Hidalgo, Denny Schanze, Ariana Kariminejad, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neu-Laxova syndrome is a heterogeneous metabolic disorder caused by defects in enzymes of the L-serine biosynthesis pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ajhg.2014.07.012"}], "href": "https://doi.org/10.1016/j.ajhg.2014.07.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25152457"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25152457"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Recep Nigdelioglu, Robert B Hamanaka, Angelo Y Meliton, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transforming Growth Factor (TGF)-β Promotes de Novo Serine Synthesis for Collagen Production."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M116.756247"}], "href": "https://doi.org/10.1074/jbc.M116.756247"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27836973"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27836973"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Thiago R Cavole, Eduardo Perrone, Felipe S C Lucena de Castro, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Clinical, molecular, and pathological findings in a Neu-Laxova syndrome stillborn: A Brazilian case report."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Med Genet A (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ajmg.a.61559"}], "href": "https://doi.org/10.1002/ajmg.a.61559"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32196970"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32196970"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Wen-Bin Guo, Zhen-Hui Huang, Cheng Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Down regulating PHGDH affects the lactate production of sertoli cells in varicocele."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Reprod Biol Endocrinol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12958-020-00625-9"}], "href": "https://doi.org/10.1186/s12958-020-00625-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32664979"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32664979"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Woo-Cheol Sim, Wonseok Lee, Hyungtai Sim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of PHGDH expression and hepatic serine level contribute to the development of fatty liver disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Metabolism (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.metabol.2019.154000"}], "href": "https://doi.org/10.1016/j.metabol.2019.154000"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31678070"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31678070"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Sakari Mäntyselkä, Kalle Kolari, Philipp Baumert, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Serine synthesis pathway enzyme PHGDH is critical for muscle cell biomass, anabolic metabolism, and mTORC1 signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Endocrinol Metab (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpendo.00151.2023"}], "href": "https://doi.org/10.1152/ajpendo.00151.2023"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37991454"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37991454"}]}]}]}
|
| Synonyms | 3PGDH, HEL-S-113, SERA, PDG, PGAD, PHGDHD, NLS, PGD, NLS1, 3-PGDH |
| Proteins | SERA_HUMAN |
| NCBI Gene ID | 26227 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
PHGDH has 20,661 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, disease, phenotype or trait, functional term, phrase or reference, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 144 datasets.
Click the + buttons to view associations for PHGDH from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PHGDH gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of PHGDH gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PHGDH gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of PHGDH gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of PHGDH gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PHGDH gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of PHGDH gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PHGDH gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PHGDH gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of PHGDH gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of PHGDH gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of PHGDH gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with PHGDH protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with PHGDH gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PHGDH gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of PHGDH gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of PHGDH gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations | phenotypes associated with PHGDH gene from the curated ClinVar Gene-Phenotype Associations dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with PHGDH gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CM4AI U2OS Cell Map Protein Localization Assemblies | assemblies containing PHGDH protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PHGDH gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing PHGDH protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing PHGDH protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores | cellular components containing PHGDH protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 | cellular components containing PHGDH protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with PHGDH protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with PHGDH protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of PHGDH gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with PHGDH gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with PHGDH gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with PHGDH gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with PHGDH gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of PHGDH protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by PHGDH gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores | diseases involving PHGDH gene from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores 2025 | diseases involving PHGDH gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with PHGDH gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with PHGDH gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with PHGDH gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with PHGDH gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with PHGDH gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for PHGDH protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PHGDH gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PHGDH gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of PHGDH gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing PHGDH from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with PHGDH gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with PHGDH gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of PHGDH gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with PHGDH gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing PHGDH from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of PHGDH gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PHGDH gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of PHGDH gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PHGDH gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of PHGDH gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of PHGDH gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving PHGDH gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving PHGDH gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving PHGDH gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing PHGDH protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing PHGDH protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by PHGDH gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by PHGDH gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by PHGDH gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of PHGDH gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of PHGDH gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of PHGDH gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PHGDH gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of PHGDH gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations | phenotypes associated with PHGDH gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with PHGDH gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with PHGDH gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with PHGDH gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of PHGDH gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for PHGDH protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of PHGDH gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of PHGDH gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of PHGDH protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PHGDH gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HPM Cell Type and Tissue Protein Expression Profiles | cell types and tissues with high or low expression of PHGDH protein relative to other cell types and tissues from the HPM Cell Type and Tissue Protein Expression Profiles dataset. | |
| HPO Gene-Disease Associations | phenotypes associated with PHGDH gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for PHGDH from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with PHGDH gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| HumanCyc Pathways | pathways involving PHGDH protein from the HumanCyc Pathways dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by PHGDH gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for PHGDH protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of PHGDH gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of PHGDH gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of PHGDH gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways | pathways involving PHGDH protein from the KEGG Pathways dataset. | |
| KEGG Pathways 2026 | pathways involving PHGDH protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of PHGDH gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of PHGDH gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with PHGDH gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of PHGDH gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of PHGDH gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of PHGDH gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PHGDH gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain PHGDH protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by PHGDH gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting PHGDH gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of PHGDH gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of PHGDH gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by PHGDH gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of PHGDH gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| MW Enzyme Metabolite Associations | interacting metabolites for PHGDH protein from the MW Gene Metabolite Associations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of PHGDH gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| NURSA Protein Complexes | protein complexs containing PHGDH protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| OMIM Gene-Disease Associations | phenotypes associated with PHGDH gene from the curated OMIM Gene-Disease Associations dataset. | |
| PANTHER Pathways | pathways involving PHGDH protein from the PANTHER Pathways dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for PHGDH from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PHGDH gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of PHGDH gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving PHGDH protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving PHGDH protein from the Wikipathways PFOCR 2024 dataset. | |
| Phosphosite Textmining Biological Term Annotations | biological terms co-occuring with PHGDH protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset. | |
| PhosphoSitePlus Substrates of Kinases | kinases that phosphorylate PHGDH protein from the curated PhosphoSitePlus Substrates of Kinases dataset. | |
| ProteomicsDB Cell Type and Tissue Protein Expression Profiles | cell types and tissues with high or low expression of PHGDH protein relative to other cell types and tissues from the ProteomicsDB Cell Type and Tissue Protein Expression Profiles dataset. | |
| Reactome Pathways 2014 | pathways involving PHGDH protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving PHGDH protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of PHGDH gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of PHGDH gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of PHGDH gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of PHGDH gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PHGDH gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PHGDH gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of PHGDH gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of PHGDH gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with PHGDH protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of PHGDH gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of PHGDH gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of PHGDH gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of PHGDH gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of PHGDH gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of PHGDH gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of PHGDH protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PHGDH protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of PHGDH protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PHGDH protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with PHGDH protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with PHGDH protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving PHGDH protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving PHGDH protein from the WikiPathways Pathways 2024 dataset. | |